Skip to main content

Top Bar Menu

Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • News Library

Sign Up For Emails

Patient Gateways

Top Bar Menu

Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • News Library

Main navigation

Close Menu
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials

Patient Gateway

News Library

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

  • Article title with healthcare image design

    Article

    August 02, 2023

    Decentralized Trials: Bringing Clinical Trials Closer to the Patient

    While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to...
    READ MORE about Decentralized Trials: Bringing Clinical Trials Closer to the Patient ›
  • ILCSC banner

    Article

    July 18, 2023

    LUNGevity's International Lung Cancer Survivorship Conference

    LUNGevity's 2023 International Lung Cancer Survivorship Conference features something for everyone! Our lineup of internationally renowned lung cancer experts will be covering a...
    READ MORE about LUNGevity's International Lung Cancer Survivorship Conference ›
  • Cover image with video title and photos of speakers

    Video

    July 17, 2023

    We have succeeded in targeting KRAS G12C mutations. Now what?

    We currently have two FDA-approved drugs, sotorasib and adagrasib, that are used to treat advanced-stage NSCLC with KRAS G12C mutations. Watch the discussion with guest speakers...
    READ MORE about We have succeeded in targeting KRAS G12C mutations. Now what? ›
  • Highlights of lung cancer research title over a doctor talking with a patient

    Article

    June 22, 2023

    2023 ASCO: Highlights of Lung Cancer Research

    Recently, members of LUNGevity Foundation joined thousands of attendees from the US and around the world, including oncologists, scientists, biotech and pharmaceutical...
    READ MORE about 2023 ASCO: Highlights of Lung Cancer Research ›
  • A beach scene

    Article

    May 31, 2023

    Linda I. Shares Her Story

    I was told on October 11, 2007, that I had non-small cell lung cancer (NSCLC). I was 46 years old with 2 kids — 7 and 12 year olds — at home waiting for me. I had an MRI and PET...
    READ MORE about Linda I. Shares Her Story ›
  • graphic with title of webinar

    Video

    May 31, 2023

    Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care

    Join us for a discussion on lung cancer biomarkers to learn what biomarker testing is, why it’s important, and how it can be used to optimize your treatment plans. We are thrilled...
    READ MORE about Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care ›
  • Photo of Dr. Swanton with title of post

    Article

    May 23, 2023

    Tracing the Clues of a Global Killer: How Dr. Charles Swanton’s Research Is Shedding New Light on Lung Cancer

    As Chief Investigator of the groundbreaking Cancer Research UK (CRUK) TRACERx study, you could say that Dr. Charles Swanton is having a moment. Launched nine years ago, TRACERx...
    READ MORE about Tracing the Clues of a Global Killer: How Dr. Charles Swanton’s Research Is Shedding New Light on Lung Cancer ›
  • Graphic with event title

    Video

    May 15, 2023

    EGFR+ Lung Cancer: Going Beyond Osimertinib

    Learn about what's next once osimertinib stops working in EGFR+ lung cancer. EGFR Resisters co-founders Jill Feldman and Ivy Elkins, and 2021 EGFR Resisters/LUNGevity Foundation...
    READ MORE about EGFR+ Lung Cancer: Going Beyond Osimertinib ›
  • Blog title and Lauren Byers smiling photo

    Article

    May 09, 2023

    The Basics of Neuroendocrine Tumors (NETs)

    Our lung tissue is made of different kinds of cells, including neuroendocrine cells. If these cells develop changes in their genome, they can begin to grow out of control and...
    READ MORE about The Basics of Neuroendocrine Tumors (NETs) ›
  • Background showing DNA

    Article

    May 03, 2023

    Caregiver Spotlight: Myra Aldarondo

    In the spring of 2021, Myra’s husband Kelvin had COVID-19. After, he had a lingering cough and shortness of breath. His chest hurt a bit when he breathed. They assumed it was...
    READ MORE about Caregiver Spotlight: Myra Aldarondo ›
  • Background showing DNA

    Article

    May 03, 2023

    A Survivor’s Experience with Biomarker Testing and TKI Treatments

    Back in 2013, when Dan Cadigan was first diagnosed with stage III lung cancer, his treatment options were limited to surgery followed by chemotherapy. However, at his one-year...
    READ MORE about A Survivor’s Experience with Biomarker Testing and TKI Treatments ›
  • Running feet

    Article

    May 03, 2023

    Survivor Spotlight: Randi Young and Sharon Schneider Found Their Footing with Team LUNGevity

    Team LUNGevity attracts experienced athletes, newcomers, and everyone in between. Many run, bike, or swim in honor or in memory of someone diagnosed with lung cancer, but lung...
    READ MORE about Survivor Spotlight: Randi Young and Sharon Schneider Found Their Footing with Team LUNGevity ›

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Next page Next ›
  • Last page Last »
SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2025 LUNGevity Foundation. All rights reserved.